or Try an Advanced Search...

    Technical Analysis for OPT - Opthea Limited

    Grade Last Price % Change Price Change
    F 1.90 -1.50% -0.03
    OPT closed down 1.5 percent on Monday, July 1, 2024, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical OPT trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Narrow Range Bar Range Contraction -1.50%
    Inside Day Range Contraction -1.50%
    Wide Bands Range Expansion -1.50%
    Gapped Up Strength -1.50%
    Oversold Stochastic Weakness -1.50%
    Wide Bands Range Expansion 2.20%
    Oversold Stochastic Weakness 2.20%
    Shooting Star Candlestick Bearish 1.12%
    Older End-of-Day Signals for OPT ...

       Recent Intraday Alerts

    Alert Time
    Down 2 % about 6 hours ago
    Down 1% about 6 hours ago
    60 Minute Opening Range Breakdown about 6 hours ago
    Fell Below 10 DMA about 6 hours ago
    Rose Above Previous Day's High about 9 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    OPT Chart by TradingView
    Basic chart:

    Profile

    Opthea Limited operates as a biotechnology company. The Company develops therapies for diabetic macular edema, corneal neovascularization and transplantation, and dry eye disease. Opthea serves patients and healthcare providers in Australia.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Organ Systems Diabetes Eye Healthcare Providers Ophthalmology Transplantation Diabetic Retinopathy Eye Diseases Macular Edema Diabetic Macular Edema Blindness Cornea Dry Eye Disease Angiology

    Is OPT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 19 Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
    Jun 13 Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$171.5 million (US$113.2m¹)
    Jun 12 Opthea announces placement, entitlement offer to raise up to $150M
    Jun 12 Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately A$227.3 million (US$150.0 million¹)
    Jun 3 Opthea To Present at Clinical Trials at the Summit Meeting
    May 28 Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
    May 1 Opthea Announces Upcoming Presentations at the Retina World Congress 2024
    Apr 25 Opthea to Present at the OIS Retina Innovation Summit at ARVO
    Apr 12 Owning 39% shares,institutional owners seem interested in Opthea Limited (ASX:OPT),
    Apr 4 Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conference
    See more OPT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.4
    52 Week Low 1.6
    Average Volume 26,455
    200-Day Moving Average 2.70
    50-Day Moving Average 3.00
    20-Day Moving Average 2.32
    10-Day Moving Average 1.92
    Average True Range 0.22
    RSI (14) 25.93
    ADX 32.14
    +DI 19.03
    -DI 29.00
    Chandelier Exit (Long, 3 ATRs) 2.73
    Chandelier Exit (Short, 3 ATRs) 2.44
    Upper Bollinger Bands 3.26
    Lower Bollinger Band 1.38
    Percent B (%b) 0.28
    BandWidth 81.02
    MACD Line -0.36
    MACD Signal Line -0.36
    MACD Histogram -0.0038
    Fundamentals Value
    Market Cap 157.5 Million
    Num Shares 82.9 Million
    EPS -2.43
    Price-to-Earnings (P/E) Ratio -0.78
    Price-to-Sales 623.65
    Price-to-Book 4.31
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.11
    Resistance 3 (R3) 2.13 2.08 2.08
    Resistance 2 (R2) 2.08 2.03 2.07 2.06
    Resistance 1 (R1) 1.99 1.99 1.97 1.97 2.05
    Pivot Point 1.94 1.94 1.93 1.93 1.94
    Support 1 (S1) 1.85 1.89 1.83 1.83 1.75
    Support 2 (S2) 1.80 1.85 1.79 1.74
    Support 3 (S3) 1.71 1.80 1.73
    Support 4 (S4) 1.69